HuagongsheHuagongshe Chemistry Print Report · For research reference only
Potassium Hydroxide → HCID 86711100, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Potassium Hydroxide | HCID 14797 | — |
| Reactant | Vemurafenib | HCID 42611257 | — |
| Reactant | 1-Chloroethyl 2-((tert-butoxycarbonyl)amino)-3-methylbutanoate | HCID 86711099 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 86711100 | HCID 86711100 | 65% |
Reaction Steps
The title compound was prepared according to the procedure as described in Example 14 step 2 using N-(3-(5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide (0.3 g, 0.61 mmol) in anhydrous DMF (2.5 mL), KOH (69 mg, 1.22 mmol) and a solution of 1-chloroethyl 2-((tert-butoxycarbonyl)amino)-3-methylbutanoate (172 mg, 0.61 mmol) in anhydrous DMF (0.5 mL). The crude product was purified by a silica gel column chromatography (PE/EtOAc (v/v)=4/1 to 3/1) to afford the title compound as orange oil (0.29 g, 65%). The title compound was characterized by 1H NMR as shown below:
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09399639B2 |
| Source dataset | uspto-grants-2016_07 |
| ORD ID | ord-94eb571fcad54c98a53877052a5fb3eb |
| Source note | uspto-grants-2016_07 |